Medical Aesthetics Market To Surge US$ 46.1 Billion By 2033

Introduction

Global Medical Aesthetics Market size is expected to be worth around USD 46.1 billion by 2033 from USD 16.1 billion in 2023, growing at a CAGR of 11.1% during the forecast period 2024 to 2033. In 2023, North America led the market, achieving over 39.8% share with a revenue of USD 6.4 Billion.

This market growth is largely driven by advancements in non-invasive procedures such as laser and ultrasound treatments, which have not only improved outcomes for consumers but also widened the appeal of aesthetic treatments. Despite these advancements, the market faces challenges including the high costs associated with medical aesthetic procedures, particularly in developing regions where these costs limit accessibility. Additionally, the lack of comprehensive insurance coverage for these treatments exacerbates affordability issues, which could deter broader adoption.

Recent industry developments further illustrate the dynamic nature of the medical aesthetics sector. Notably, in June 2023, the FDA approved new laser treatments for pediatric skin conditions, marking significant regulatory progress and innovation. Moreover, companies like Allergan Aesthetics are actively promoting racial and ethnic diversity, reflecting a deeper industry commitment to inclusivity.

Overall, the medical aesthetics market is positioned for continued growth despite potential economic uncertainties that could impact discretionary spending on aesthetic treatments. Strong market fundamentals such as rising consumer demand, ongoing product innovation, and significant investments from both private and corporate investors support a positive outlook. This growth is expected to be driven by both technological advancements and shifting consumer preferences towards personalized, minimally invasive treatments.

Key Takeaways

• Market Growth Projection: The global medical aesthetics market is projected to reach USD 51.7 billion by 2032, growing at a CAGR of 13.3%.
• Procedure Trends: Dominated by non-invasive treatments, the market favors soft tissue fillers, chemical peels, and Botox due to less pain and lower costs.
• Leading Application: Skin resurfacing and tightening command the largest share, fueled by increased demand for advanced skin rejuvenation technologies.
• Primary End Users: Hospitals and clinics lead as primary providers of advanced aesthetic treatments, with home care gaining traction for its affordability and convenience.
• Key Market Drivers: Growth is spurred by the rising preference for minimally invasive treatments, the popularity of home-based aesthetic solutions, and ongoing technological innovations.
• Market Constraints: Social and ethical concerns, along with the stigma around cosmetic treatments, pose challenges to market growth.
• Regional Dominance and Potential: North America holds over 35% of the market revenue, while Asia Pacific is poised for the fastest growth, led by China, India, and South Korea.

Medical Aesthetics Statistics

• Popularity of Non-Surgical Procedures
  • U.S. Trends: In 2015, non-surgical cosmetic procedures reached 14.2 million in the U.S., emphasizing the growing preference for less invasive treatments.
  • UK Market Growth: The UK’s non-surgical aesthetics sector is expected to exceed a market value of £3 billion next year, indicating robust demand.
  • Expenditure Trends: By 2015, non-surgical procedures represented 42% of the total aesthetics industry expenditures in the U.S., exceeding $5 billion for the first time.
• Surgical vs. Non-Surgical Dynamics
  • China’s Preferences: In 2020, surgical procedures accounted for about 69% of China’s medical aesthetics services market.
  • U.S. Market Dynamics: Between 2021, surgical aesthetic procedures in the U.S. saw a 54% surge, while non-surgical treatments grew by 44%.
• Specific Procedures and Demographics
  • Rapid Growth Areas: Body-focused non-surgical treatments witnessed the highest growth at 63% in 2021. Skin rejuvenation within non-surgical procedures garnered around $1.9 billion in the same year, showing significant growth.
  • Men’s Preferences: Non-surgical skin tightening moved up to become the 5th most popular procedure among men.
  • Professional Activity: On average, each plastic surgeon performed 320 surgical procedures in 2021, a significant increase from 220 in 2020.
• Costs and Gender Distribution
  • Cost Analysis: In 2021, the cost for surgical procedures rose by 6%, whereas non-surgical procedure costs saw a modest increase of 1%.
  • Gender Trends: Women accounted for 94% of all cosmetic procedures in 2021. Notably, women aged 17-35 primarily opted for breast augmentations, while liposuction was the most common surgery for women aged 36-50 and continued to be favored by those aged 51-70.
• Procedure Specific Data
  • Breast Procedures: In 2021, breast augmentations totaled 365,000, including 148,000 implant replacements—a 32% increase from the previous year. Furthermore, 71,000 women had breast implant removals without replacements, marking a 47% increase.
  • Facial Enhancements: Facial procedures surged by 55% in 2021, largely influenced by the “Zoom Effect” on consumer demand.
  • Male Surgical Choices: For men, liposuction was the top surgical cosmetic procedure, followed by gynecomastia surgery and blepharoplasty, emphasizing the trend towards body contouring and facial enhancements among male patients.

Emerging Trends

• Technology and AI Integration: The incorporation of Artificial Intelligence (AI) in aesthetic medicine is increasingly prominent. AI is employed for facial analysis during virtual consultations, guiding recommendations for treatments such as neurotoxins, fillers, or lasers. Additionally, advanced imaging is utilized to create 3D facial models, helping simulate potential outcomes and facilitating precise treatment planning.
• Regenerative Treatments and Microneedling: There is a marked shift towards regenerative treatments that leverage a patient’s own cells, such as PRP, exosomes, and stem cells, to enhance the skin’s natural healing processes. Concurrently, microneedling is gaining traction for its efficacy in promoting skin rejuvenation, achieving the coveted ‘glass skin’ look noted for its smooth, hydrated appearance.
• Consumer-Driven Market Shifts: Economic considerations are prompting consumers to seek cost-effective aesthetic treatments, yet strong brand loyalty remains evident. This has spurred the emergence of new, affordable service-delivery models. Moreover, the demographic range of consumers engaging with aesthetic treatments is broadening, indicating a growing acceptance of these procedures across various groups.
• Advancements in Non-Invasive Procedures: The field is experiencing a rise in non-invasive treatments, such as needle-free enhancements and minimally invasive neck lifts, which promise significant aesthetic benefits with minimal recovery time. These methods align with the prevailing preference for natural-looking enhancements over more conspicuous alterations.
• Holistic Wellness and Aesthetic Integration: The convergence of wellness and aesthetics is becoming more pronounced, with treatments increasingly addressing both immediate aesthetic desires and long-term health benefits. This trend is embodied by the growth of medical weight-loss clinics and IV therapy programs that pair wellness solutions with traditional aesthetic procedures.
• Personalized and Diverse Aesthetic Approaches: The industry is evolving to celebrate individual beauty and diversity, employing techniques that accentuate rather than alter natural features. This movement away from universal solutions toward tailored, personalized care highlights a broader shift towards embracing the unique characteristics of each individual.

Use Cases

• Broadening Acceptance and Consumer Diversity: The acceptance of non-invasive aesthetic treatments has surged, with a McKinsey report highlighting that 81% of consumers are now more open to these procedures than they were five years ago. This shift is greatly influenced by social media, which has normalized aesthetic treatments and expanded their appeal to a wider, more diverse audience, including a notable rise in male consumers.
• Expansion of Access Points: The landscape for accessing medical aesthetic services has broadened significantly. The proliferation of aesthetics clinic chains, med spas, and beauty bars offers convenient access to treatments, reflecting a positive market outlook fueled by significant private equity investments.
• Technological Advancements in Procedures: Innovative technologies continue to transform the medical aesthetics field. Developments include longer-lasting neuromodulators and dermal fillers, as well as the use of energy-based devices like ultrasound and radiofrequency for enhanced skin tightening and body contouring.
• Integration of Robotic Technologies: The adoption of advanced technologies, such as robotic surgery, is on the rise in the medical aesthetics sector. These innovations are improving the precision of procedures such as knee arthroplasties and enhancing patient outcomes through less invasive techniques.
• Growth in Targeted Procedures: Specific aesthetic procedures, including skin resurfacing, body contouring, and laser hair removal, are experiencing significant growth. This is driven by increased consumer awareness and technological improvements that enhance the accessibility and effectiveness of these treatments.

Key Player Analysis

• AbbVie Inc.: Since acquiring Allergan in 2020, AbbVie Inc. has significantly enhanced its capabilities within the global medical aesthetics market. This strategic acquisition has bolstered the company’s research and development efforts, focusing on innovative aesthetic medicine solutions. AbbVie’s robust market presence is supported by an extensive product portfolio and pipeline, underpinned by advanced data analytics and consumer insights, positioning it for continued growth through technological innovations and expert capabilities.
• Sisram Medical Ltd.: Sisram Medical Ltd. reported a revenue of US$359.3 million in 2023, a modest year-over-year increase of 1.4%. The company has fortified its market presence through continuous innovation in R&D, launching products like Soprano Titanium and Alma Veil in North America, and expanding its injectables line. A significant contributor to their revenue was their direct sales strategy, which achieved a record US$281 million in 2023, highlighting their expanding influence in the global market.
• Merz Aesthetics: Merz Aesthetics continues to lead in innovation and scientific exchange within the medical aesthetics industry. In 2023, the company showcased its commitment by highlighting new trends in regenerative aesthetics and presenting a robust product portfolio at key industry events like the Aesthetic and Anti-Aging Medicine World Congress. Their active participation in global forums underscores their dedication to enhancing healthcare professionals’ abilities to deliver superior patient outcomes.
• Cutera Inc.: Cutera Inc. demonstrated a strong market presence with its 2023 revenue reaching approximately $205 million. The company is renowned for its advanced non-surgical solutions, including innovative treatments like AviClear for acne and truBody for body sculpting. Cutera’s commitment to technology-driven, high-performance aesthetic improvements is evident in their approach, which focuses on customer satisfaction and clinical efficacy, making them a top choice for practitioners globally.
• Medytox, Inc.: Medytox, Inc., a key South Korean biopharmaceutical company, has carved a significant niche in the global medical aesthetics market, particularly with its botulinum toxin products. Since launching Meditoxin in 2006, Medytox has captured nearly 40% market share, with a diverse portfolio that underscores its strategic focus on innovation and expansion.
• Solta Medical Inc.: A division of Bausch Health Companies Inc., Solta Medical Inc. specializes in innovative, energy-based medical devices for aesthetic treatments. Known for products like Thermage, Fraxel, and Clear + Brilliant, the company offers solutions for skin rejuvenation, tightening, and body contouring. With over two decades of expertise, Solta Medical has established a reputation for delivering effective aesthetic solutions with minimal downtime, catering to a broad range of skin treatment needs in over 50 countries.
• Sientra Inc.: Based in Irvine, California, Sientra Inc. specializes in surgical aesthetics products, including FDA-approved fifth-generation breast implants and innovative tissue expanders like AlloX2 and AlloX2Pro™. Despite facing financial challenges leading to a Chapter 11 bankruptcy filing in February 2024, Sientra continues operations with significant debtor-in-possession financing, supporting ongoing service and product availability while seeking potential company sale opportunities.
• Johnson & Johnson and Hologic Inc.: These entities are pivotal in the growing medical aesthetics sector. Recently, Hologic Inc. divested its Cynosure medical aesthetics division to Clayton, Dubilier & Rice, which is now poised for accelerated growth, focusing on advanced light-based technologies for skin and body treatments and women’s health.
• Sciton Inc.: Based in Palo Alto, California, Sciton has excelled in the medical aesthetics sector with its advanced laser and light source technologies. Celebrating over 25 years of innovation, Sciton’s JOULE and mJOULE platforms provide versatile treatments for skin rejuvenation, wrinkle reduction, and scar treatment. The company’s commitment to excellent customer service and technological advancement has solidified its strong market position.
• Bausch Health Companies Inc.: Through its subsidiary, Solta Medical, Bausch Health Companies Inc. remains a leader in the medical aesthetics market, providing cutting-edge skin rejuvenation and body contouring solutions. With a track record of over six million procedures performed globally, Solta Medical’s significant revenue growth demonstrates robust demand for their aesthetic solutions.

Conclusion

The medical aesthetics market is poised for significant growth, driven by the rising demand for non-invasive procedures and technological advancements in aesthetic treatments. Despite challenges such as high costs and limited insurance coverage, the sector shows resilience with innovations like AI integration and regenerative treatments enhancing consumer outcomes.

The market benefits from increasing inclusivity and broadening consumer demographics, indicating a shift towards personalized, less invasive treatments. With key players like AbbVie Inc. and Cutera Inc. leading the charge, the industry is set to expand further, supported by strong investment and evolving consumer preferences.

Discuss Your Needs With Our Analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

Request a Sample Download PDF